EUVIMED · CrossrefZeitschrift
JCC Plus
ISSN 3066-943X · Wiley
Neueste Artikel
Feasibility of a Multimodal Lifestyle Intervention Programme for Patients With Ulcerative Colitis: A Single‐Arm Pilot Study
Shared Decision Making in Inflammatory Bowel Disease: A Multi‐Stakeholder Survey of Patients' and Healthcare Professionals' Knowledge, Preferences, and Experiences in Belgium
TL1A in the Pathophysiology of Perianal Fistulising Crohn's Disease
Welcome to JCC Plus —A New Chapter in the ECCO Story
Issue Information
Advancing Clinical Trial Methodology and Reporting of Outcomes for Exclusive Enteral Nutrition and Partial Enteral Nutrition in Crohn's Disease: Challenges and Recommendations
Issue Information
The Incidence of Inflammatory Bowel Disease in Otago, New Zealand 1996–2024: A 28‐Year Analysis
Patients' Experiences at the Inflammatory Bowel Disease Outpatient Clinic During the Pandemic—Healthcare Service Offer and Apprehension of Consequences of COVID‐19
The Role of Young Society Committees in Building Tomorrow's IBD Experts
How to Conduct Impactful and Sustainable Clinical Research in IBD: A Toolbox for Researchers
From Kitchen to Inflammatory Bowel Disease (IBD) Clinic: Transforming the Role of Dietitians in IBD Care. A Narrative Review by Dietitians With Expertise in IBD
Endoscopic Sampling Impact on PICaSSO Histologic Remission Index Scoring in Ulcerative Colitis
Gaps Between European Crohn's Colitis Organisation Quality Standards of Care and the Real World in Special Situations in Inflammatory Bowel Disease Across Europe: Results From E‐QUALITY Survey
Real‐World Comparison of Vedolizumab and Ustekinumab in TNF Inhibitor–Experienced Ulcerative Colitis Patients Followed by Therapeutic Drug Monitoring
Altered Levels of Enteric Glial Cells and Their Associated Pro‐Inflammatory Proteins in Patients With Ulcerative Colitis During Active Disease Compared to Remission and Healthy Controls
IBD Care Organisation of the Future: Value for Money
Association Between 1‐Year Endoscopic Outcomes and Long‐Term Clinical and Patient‐Relevant Outcomes in Crohn's Disease
The Crohn's Disease Exclusion Diet Across the Lifespan, Indications and the Globe: An Expert Review Towards Personalized Therapy in Crohn's Disease
Behavioural and Occupational Adaptations in Predominantly Vaccinated Individuals Living With Inflammatory Bowel Disease During the COVID‐19 Pandemic
Establishing a Central Reader Pool for Magnetic Resonance Enterography Scoring in Crohn's Disease Clinical Trials
Empowering Patient Voices: Revolutionising Inflammatory Bowel Disease Research Through Patient and Public Involvement
Exploring the Perceptions and Practices of Exclusive Enteral Nutrition Among Adult Patients With Inflammatory Bowel Disease, Gastroenterologists and Dietitians in Australia
Early Initiation of Anti‐TNF Biosimilar in Newly Diagnosed Moderate and Severe Crohn's Disease: Health Economic Insights From the PROFILE Trial
Efficacy of Filgotinib for Treating Chronic Antibiotic‐Dependent Pouchitis: A Pilot Study
Transmural Assessment at Ulcerative Colitis Diagnosis: From Prognostication to Treatment Target
Systematic Review: The Impact of Geographic Location and Socioeconomic Status on Healthcare Utilisation and Clinical Outcomes in Patients With Inflammatory Bowel Disease (IBD) in the Developed World
CAR‐T Cells in Ulcerative Colitis: The Renaissance of B‐Cell Targeted Therapy in UC
Mesenteric Lymphatic Dysfunction as the Initiating Event in Crohn's Disease: Toward an Outside‐In Paradigm
Fibroblast Activation Protein Expression Differs Between Inflamed and Fibrostenotic Inflammatory Bowel Disease
EUVIMED